Xenon Pharmaceuticals Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	199.16	142.71	148.64	57.24	175.69
Short-Term Investments	349.72	484.19	489.44	534.85	376.09
Cash & Short-Term Investments	548.89	626.91	638.08	592.09	551.77
Cash Growth	-12.45%	-1.75%	7.77%	7.31%	211.74%
Accounts Receivable	1.37	1.47	0.87	0.99	2.77
Receivables	1.37	1.47	0.87	0.99	2.77
Prepaid Expenses	10.39	6.89	6.01	7.23	4.48
Total Current Assets	560.65	635.26	644.96	600.3	559.02
Property, Plant & Equipment	15.35	18.22	18.85	16.91	12.52
Long-Term Investments	37.15	127.5	292.79	128.68	-
Long-Term Deferred Tax Assets	12.86	9.67	0.8	0.51	0.47
Other Long-Term Assets	7.15	7.5	7.4	7.75	-
Total Assets	633.16	798.14	964.8	754.15	572.01
Accounts Payable	3.89	5.07	8.6	8.49	3.82
Accrued Expenses	36.06	23.47	17.03	13.38	9.78
Current Portion of Leases	1.53	1.37	1.3	0.49	0.61
Current Income Taxes Payable	0.31	5.69	0.35	-	-
Other Current Liabilities	-	-	-	0.34	0.12
Total Current Liabilities	41.79	35.59	27.27	22.7	14.32
Long-Term Leases	6.41	7.65	9.6	9.95	7.65
Other Long-Term Liabilities	3.2	-	-	-	-
Total Liabilities	51.4	43.24	36.88	32.65	21.97
Common Stock	1,599	1,457	1,436	1,065	790.9
Additional Paid-In Capital	228.23	199.15	156.76	142.11	117.5
Retained Earnings	-1,245	-899.47	-665.14	-482.75	-357.37
Comprehensive Income & Other	0.34	-1.61	-0.08	-3	-0.99
Shareholders' Equity	581.76	754.9	927.92	721.5	550.03
Total Liabilities & Equity	633.16	798.14	964.8	754.15	572.01
Total Debt	7.94	9.02	10.9	10.44	8.26
Net Cash (Debt)	578.09	745.39	919.97	710.33	543.52
Net Cash Growth	-22.44%	-18.98%	29.51%	30.69%	212.94%
Net Cash Per Share	7.29	9.57	13.75	11.73	12.46
Filing Date Shares Outstanding	83.19	76.54	75.43	63.04	52.94
Total Common Shares Outstanding	80.01	76.42	75.37	62.59	52.65
Working Capital	518.86	599.67	617.69	577.6	544.7
Book Value Per Share	7.27	9.88	12.31	11.53	10.45
Tangible Book Value	581.76	754.9	927.92	721.5	550.03
Tangible Book Value Per Share	7.27	9.88	12.31	11.53	10.45
Machinery	14.76	14.38	11.89	11	10.8
Leasehold Improvements	9.41	9.36	9.02	4.2	7.02

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q